» Articles » PMID: 31826327

Design, Construction, and Biological Testing of an Implantable Porous Trilayer Scaffold for Repairing Osteoarthritic Cartilage

Overview
Date 2019 Dec 12
PMID 31826327
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Various tissue engineering systems for cartilage repair have been designed and tested over the past two decades, leading to the development of many promising cartilage grafts. However, no one has yet succeeded in devising an optimal system to restore damaged articular cartilage. Here, the design, assembly, and biological testing of a porous, chitosan/collagen-based scaffold as an implant to repair damaged articular cartilage is reported. Its gradient composition and trilayer structure mimic variations in natural cartilage tissue. One of its layers includes hydroxyapatite, a bioactive component that facilitates the integration of growing tissue on local bone in the target area after scaffold implantation. The scaffold was evaluated for surface morphology; rheological performance (storage, loss, complex, and time-relaxation moduli at 1 kHz); physiological stability; in vitro activity and cytotoxicity (on a human chondrocyte C28 cell line); and in vivo performance (tissue growth and biodegradability), in a murine model of osteoarthritis. The scaffold was shown to be mechanically resistant and noncytotoxic, favored tissue growth in vivo, and remained stable for 35 days postimplantation in mice. These encouraging results highlight the potential of this porous chitosan/collagen scaffold for clinical applications in cartilage tissue engineering.

Citing Articles

Tissue engineering strategies hold promise for the repair of articular cartilage injury.

Yang C, Chen R, Chen C, Yang F, Xiao H, Geng B Biomed Eng Online. 2024; 23(1):92.

PMID: 39261876 PMC: 11389311. DOI: 10.1186/s12938-024-01260-w.


The Incorporation of Etanercept into a Porous Tri-Layer Scaffold for Restoring and Repairing Cartilage Tissue.

Campos Y, Fuentes G, Almirall A, Que I, Schomann T, Chung C Pharmaceutics. 2022; 14(2).

PMID: 35214015 PMC: 8878505. DOI: 10.3390/pharmaceutics14020282.